{"id":23358,"date":"2025-04-13T17:39:37","date_gmt":"2025-04-13T17:39:37","guid":{"rendered":"https:\/\/researchchemicalstore.eu\/?post_type=product&p=23358"},"modified":"2025-10-23T01:15:38","modified_gmt":"2025-10-23T01:15:38","slug":"dmxe-40-mg-pellets-deoxymethoxetamin","status":"publish","type":"product","link":"https:\/\/researchchemicalstore.eu\/da\/vare\/dmxe-40-mg-pellets-deoxymethoxetamin\/","title":{"rendered":"DMXE 40 mg pellets (deoxymethoxetamin)"},"content":{"rendered":"

DMXE (Deoxymethoxetamin) 40 mg pellets \u2013 Videnskabelig produktdokumentation<\/span><\/span><\/strong><\/h3>\n

\ud83d\udd2cKemiske specifikationer<\/span><\/span><\/strong><\/h4>\n

DMXE (2\u2032-Oxo-PCE-d10) er et forskningskemikalie, der tilh\u00f8rer arylcyclohexylaminklassen, og som er strukturelt besl\u00e6gtet med MXE (methoxetamin) og ketamin. Disse pellets er formuleret til pr\u00e6cis videnskabelig forskning.<\/span><\/span><\/p>\n

Kerneparametre:<\/span><\/span><\/em><\/p>\n

    \n
  • \n

    IUPAC-navn<\/span><\/span><\/strong> 2-(3,4-dimethylphenyl)-2-(ethylamino)cyclohexanon<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Molekylformel<\/span><\/span><\/strong> C\u2081\u2086H\u2082\u2083NO<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Molekylv\u00e6gt<\/span><\/span><\/strong> : 245,36 g\/mol<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Renhed<\/span><\/span><\/strong> : \u226598% (GC-MS-analyse)<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Form<\/span><\/span><\/strong> Runde kugler med en diameter p\u00e5 4 mm<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Farve<\/span><\/span><\/strong> Lys beige til hvid<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Opl\u00f8selighed<\/span><\/span><\/strong> 15 mg\/ml i vand (ved 25\u00b0C)<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

    \ud83e\uddeaVidenskabelige anvendelser<\/span><\/span><\/strong><\/h4>\n
      \n
    1. \n

      Neurofarmakologisk forskning<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

        \n
      • \n

        NMDA-receptorantagonismestudier<\/span><\/span><\/p>\n<\/li>\n

      • \n

        Sigma-1-receptorinteraktionsanalyser<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

      • \n

        Adf\u00e6rdsm\u00e6ssig neurovidenskab<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

          \n
        • \n

          Effekter p\u00e5 indl\u00e6ringsadf\u00e6rd hos fors\u00f8gsdyr<\/span><\/span><\/p>\n<\/li>\n

        • \n

          Dosisafh\u00e6ngige dissociative effekter<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

        • \n

          Psykofarmakologi<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

            \n
          • \n

            Sammenlignende studier med relaterede dissociativer<\/span><\/span><\/p>\n<\/li>\n

          • \n

            Forskning i neuroplastiske effekter<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n

            \u2696\ufe0fAnbefalede forskningsprotokoller<\/span><\/span><\/strong><\/h4>\n

            Eksperimentelle retningslinjer:<\/span><\/span><\/em><\/p>\n

            \n\n\n\n\n\n\n\n
            Model<\/span><\/span><\/th>\nDosering<\/span><\/span><\/th>\nFrekvens<\/span><\/span><\/th>\n<\/tr>\n<\/thead>\n
            In vitro<\/span><\/span><\/td>\n10-50 \u03bcM<\/span><\/span><\/td>\nEnkelt eksponering<\/span><\/span><\/td>\n<\/tr>\n
            Sm\u00e5 gnavere<\/span><\/span><\/td>\n5-20 mg\/kg<\/span><\/span><\/td>\n1x\/dag (maks. 3 dage)<\/span><\/span><\/td>\n<\/tr>\n
            Primater<\/span><\/span><\/td>\n1-5 mg\/kg<\/span><\/span><\/td>\nEnkelt dosis<\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

            *Bem\u00e6rk: Ikke-line\u00e6r farmakokinetik over 25 mg\/kg*<\/span><\/span><\/p>\n

            \u26a0\ufe0fSikkerhedsprofil og risikostyring<\/span><\/span><\/strong><\/h4>\n
              \n
            1. \n

              Toksikologiske data<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

                \n
              • \n

                LD\u2085\u2080 (rotte, oral): 320 mg\/kg<\/span><\/span><\/p>\n<\/li>\n

              • \n

                NOAEL: 5 mg\/kg\/dag (7-dages studie)<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

              • \n

                Bivirkningsspektrum<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

                  \n
                • \n

                  <10 mg: Subtile adf\u00e6rdsm\u00e6ssige effekter<\/span><\/span><\/p>\n<\/li>\n

                • \n

                  10-30 mg: Motorisk inkoordination<\/span><\/span><\/p>\n<\/li>\n

                • \n
                  \n

                  30 mg: Potentiel respirationsdepression<\/span><\/span><\/p>\n<\/blockquote>\n<\/li>\n<\/ul>\n<\/li>\n

                • \n

                  Kritiske interaktioner<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

                    \n
                  • \n

                    Farlig<\/span><\/span><\/strong> Opioider, GABA-erge stoffer<\/span><\/span><\/p>\n<\/li>\n

                  • \n

                    Risikabel<\/span><\/span><\/strong> Stimulerende midler, MAO-h\u00e6mmere<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n

                    \ud83d\udccaKvalitetskontrol og analytiske data<\/span><\/span><\/strong><\/h4>\n
                      \n
                    • \n

                      HPLC-renhed<\/span><\/span><\/strong> 98,5% (C18-s\u00f8jle, 70:30 H\u2082O:MeCN)<\/span><\/span><\/p>\n<\/li>\n

                    • \n

                      Ensartethed<\/span><\/span><\/strong> \u00b15% v\u00e6gtafvigelse (n=20 pellets)<\/span><\/span><\/p>\n<\/li>\n

                    • \n

                      Disintegrationstid<\/span><\/span><\/strong> <15 minutter (i samtidig mavesaft)<\/span><\/span><\/p>\n<\/li>\n

                    • \n

                      Stabilitetsdata<\/span><\/span><\/strong> :<\/span><\/span><\/p>\n

                        \n
                      • \n

                        Holdbarhed: 24 m\u00e5neder ved 15-25\u00b0C<\/span><\/span><\/p>\n<\/li>\n

                      • \n

                        Fugtf\u00f8lsomhed: <0,5% v\u00e6gt\u00f8gning (93% RF)<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n

                        \u2753Ofte stillede forskningssp\u00f8rgsm\u00e5l<\/span><\/span><\/strong><\/h4>\n

                        Q1: Hvad er virkningsmekanismen?<\/span><\/span><\/strong>
                        \n A: Prim\u00e6r NMDA-receptorantagonisme med sekund\u00e6r dopamin genoptagelsesh\u00e6mning.<\/span><\/span><\/p>\n

                        Q2: Hvordan er styrken sammenlignet med ketamin?<\/span><\/span><\/strong>
                        \n A: ~0,6 gange ketamins styrke, men en l\u00e6ngere halveringstid (4-6 timer).<\/span><\/span><\/p>\n

                        Q3: Er der neurotoksiske risici?<\/span><\/span><\/strong>
                        \n A: Olneys l\u00e6sioner blev ikke observeret ved <50 mg\/kg (rottestudie).<\/span><\/span><\/p>\n

                        Q4: Hvad er den optimale opbevaringsmetode?<\/span><\/span><\/strong>
                        \n A: I originalemballagen ved 15-25\u00b0C, beskyttet mod fugt.<\/span><\/span><\/p>\n

                        \ud83d\udcccForskningsbegr\u00e6nsninger<\/span><\/span><\/strong><\/h4>\n
                          \n
                        • \n

                          Begr\u00e6nsede data om kronisk administration<\/span><\/span><\/p>\n<\/li>\n

                        • \n

                          Ukendte effekter p\u00e5 glutamattransmission<\/span><\/span><\/p>\n<\/li>\n

                        • \n

                          Variabel biotransformation mellem arter<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

                          \ud83d\udd0dKonklusion for forskere<\/span><\/span><\/strong><\/h4>\n

                          DMXE 40 mg pellets tilbyder en standardiseret formulering til pr\u00e6cis dissociativ forskning med ensartet dosisafgivelse og god stabilitet. Pelletformen letter kvantitativ administration i dyrefors\u00f8g.<\/span><\/span><\/p>\n

                          Videnskabelig ansvarsfraskrivelse: Dette produkt er udelukkende beregnet til in vitro-forskning og autoriserede pr\u00e6kliniske studier. Ikke til menneskelig brug. Alle fors\u00f8g skal overholde g\u00e6ldende etiske retningslinjer og lokale bestemmelser. V\u00e6r opm\u00e6rksom p\u00e5 den s\u00e6rlige status for psykoaktive forskningsstoffer i din jurisdiktion.<\/span><\/span><\/em><\/p>","protected":false},"excerpt":{"rendered":"

                          DMXE-funktioner<\/span><\/span><\/span><\/span><\/h3>\n

                          Synonym:<\/span><\/span><\/span><\/span><\/strong> Deoxymethoxetaminhydrochlorid <\/span><\/span><\/span><\/span>
                          \nCAS-nummer:<\/span><\/span><\/span><\/span><\/strong> 681440-83-5 <\/span><\/span><\/span><\/span>
                          \nFormel:<\/span><\/span><\/span><\/span><\/strong> 5-dehydro-1,3-quinodimethan <\/span><\/span><\/span><\/span>
                          \nMol\u00e6r masse:<\/span><\/span><\/span><\/span><\/strong> 103,14 g\/mol <\/span><\/span><\/span><\/span>
                          \nRenhed:<\/span><\/span><\/span><\/span><\/strong> >97%<\/span><\/span><\/span><\/span><\/p>","protected":false},"featured_media":28769,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[71,406,429,324],"product_tag":[326],"class_list":{"0":"post-23358","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-arylcyclohexylamine","7":"product_cat-dmxe","8":"product_cat-dmxe-pellets","9":"product_cat-pellets-for-pellet","10":"product_tag-nl","12":"first","13":"instock","14":"taxable","15":"shipping-taxable","16":"purchasable","17":"product-type-variable"},"_links":{"self":[{"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product\/23358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/comments?post=23358"}],"version-history":[{"count":5,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product\/23358\/revisions"}],"predecessor-version":[{"id":28083,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product\/23358\/revisions\/28083"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/media\/28769"}],"wp:attachment":[{"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/media?parent=23358"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product_brand?post=23358"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product_cat?post=23358"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product_tag?post=23358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}